Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$2.6B |
| 2 |
Abbott
ABT
|
+$1.29B |
| 3 |
Home Depot
HD
|
+$1.03B |
| 4 |
Devon Energy
DVN
|
+$888M |
| 5 |
PepsiCo
PEP
|
+$880M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$1.6B |
| 2 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$1.5B |
| 3 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$1.34B |
| 4 |
Texas Instruments
TXN
|
+$1.32B |
| 5 |
Coterra Energy
CTRA
|
+$789M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.11% |
| 2 | Financials | 10.61% |
| 3 | Healthcare | 10.33% |
| 4 | Miscellaneous | 9.93% |
| 5 | Industrials | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3226
Corbus Pharmaceuticals
CRBP
$99.4M
| $520K | ﹤0.01% |
+55,455
| New | +$525K |
2026 Q2
0 quarters
|
|
3227
Heron Therapeutics
HRTX
$75.9M
| $520K | ﹤0.01% |
1,217,463
-158,904
| -12% | -$127K |
2014 Q2
48 quarters
|
|
3228
Shoulder Innovations Inc
SI
$377M
| $519K | ﹤0.01% |
25,582
+2,630
| +11% | +$40.4K |
2025 Q3
3 quarters
|
|
3229
OP Bancorp
OPBK
$225M
| $512K | ﹤0.01% |
34,185
+2,742
| +9% | +$39K |
2025 Q2
4 quarters
|
|
3230
CB Financial Services
CBFV
$190M
| $511K | ﹤0.01% |
13,470
+1,026
| +8% | +$36.6K |
2025 Q2
4 quarters
|
|
3231
Eagle Bancorp Montana
EBMT
$166M
| $500K | ﹤0.01% |
20,907
+2,571
| +14% | +$57.7K |
2025 Q2
4 quarters
|
|
3232
ALX Oncology
ALXO
$165M
| $499K | ﹤0.01% |
+241,113
| New | +$432K |
2026 Q2
0 quarters
|
|
3233
Pioneer Bancorp
PBFS
$424M
| $498K | ﹤0.01% |
29,148
+2,228
| +8% | +$33.9K |
2019 Q3
27 quarters
|
|
3234
Hamilton Beach Brands
HBB
$470M
| $496K | ﹤0.01% |
21,547
+2,368
| +12% | +$47.2K |
2024 Q2
8 quarters
|
|
3235
BCB Bancorp
BCBP
$253M
| $495K | ﹤0.01% |
46,184
+7,178
| +18% | +$73.3K |
2022 Q2
16 quarters
|
|
3236
Medallion Financial
MFIN
$273M
| $491K | ﹤0.01% |
48,138
+4,825
| +11% | +$45.6K |
2024 Q2
8 quarters
|
|
3237
Net Lease Office Properties
NLOP
$143M
| $491K | ﹤0.01% |
44,156
+3,817
| +9% | +$46K |
2023 Q4
10 quarters
|
|
3238
TriSalus Life Sciences
TLSI
$252M
| $491K | ﹤0.01% |
107,945
+23,808
| +28% | +$94.6K |
2025 Q1
5 quarters
|
|
3239
SEACOR Marine Holdings
SMHI
$235M
| $486K | ﹤0.01% |
63,560
+5,350
| +9% | +$39.7K |
2022 Q1
17 quarters
|
|
3240
CF Bankshares
CFBK
$222M
| $485K | ﹤0.01% |
14,809
+1,312
| +10% | +$38.1K |
2025 Q2
4 quarters
|
|
3241
Lifeway Foods
LWAY
$341M
| $485K | ﹤0.01% |
16,255
+2,640
| +19% | +$67.1K |
2024 Q2
8 quarters
|
|
3242
NET Power
NPWR
$111M
| $481K | ﹤0.01% |
288,276
+18,758
| +7% | +$34K |
2023 Q3
11 quarters
|
|
3243
MainStreet Bancshares
MNSB
$177M
| $480K | ﹤0.01% |
19,444
+1,643
| +9% | +$38.6K |
2025 Q2
4 quarters
|
|
3244
Inogen
INGN
$171M
| $478K | ﹤0.01% |
74,165
+6,158
| +9% | +$40.7K |
2014 Q4
46 quarters
|
|
3245
Acme United Corp
ACU
$239M
| $478K | ﹤0.01% |
10,024
+1,416
| +16% | +$62K |
2025 Q2
4 quarters
|
|
3246
America's Car Mart
CRMT
$10.9M
| $477K | ﹤0.01% |
170,922
-37,187
| -18% | -$356K |
2013 Q2
52 quarters
|
|
3247
LifeMD
LFMD
$123M
| $468K | ﹤0.01% |
113,383
+8,874
| +8% | +$39.2K |
2022 Q3
15 quarters
|
|
3248
Expensify
EXFY
$222M
| $467K | ﹤0.01% |
260,794
-119,602
| -31% | -$134K |
2021 Q4
18 quarters
|
|
3249
Escalade
ESCA
$256M
| $466K | ﹤0.01% |
24,800
-287
| -1% | -$5.31K |
2023 Q2
12 quarters
|
|
3250
BV Financial
BVFL
$178M
| $465K | ﹤0.01% |
21,941
+1,785
| +9% | +$35.7K |
2025 Q2
4 quarters
|
|
Similar funds
Charles Schwab's Q2 2026 Portfolio in Review
As of Q2 2026, Charles Schwab held 3,591 positions worth $751B, up 15% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Charles Schwab's Q2 2026 filing shows 136 new, 2,145 increased, 1,132 reduced and 153 closed positions. Its largest new stake was Honeywell Aerospace: 2,031,187 shares worth $449M. The largest sale was Qualcomm, an estimated $1.6B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2026 buy was Honeywell Aerospace: 2,031,187 shares worth $449M.
- Charles Schwab added most to Schwab US Large-Cap Growth ETF in Q2 2026, an estimated $2.6B increase.
- Charles Schwab's biggest Q2 2026 reduction was Qualcomm, cutting an estimated $1.6B.
- Charles Schwab fully exited Coterra Energy in Q2 2026, selling an estimated $789M.
- Charles Schwab's ten largest holdings make up 22% of its $751B portfolio in Q2 2026.
- Charles Schwab opened 136 new positions and closed 153 in Q2 2026.
- Charles Schwab's portfolio value rose 15% quarter-over-quarter to $751B.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.